Bronchology – Past, Present and Future Diagnostic Procedures
29
27. Ikeda, “Atlas of Flexible Bronchoscopy.” – (1974).
28. Jesionek A, von Tappeiner H (1904).
“Behandlung der Hautcarcinome mit fluoreszierenden
Stoffen.”
Dtsch Arch Klin Med 82, 223-227.
29. Kato H, Konaka C, Hayata Y, Ono J, Imura I,
Matsushima Y (1982).
“Lung cancer histogenesis following in vivo bronchial
injections of 20-methycholanthrene in dogs.”
Recent Results Cancer Res 82, 69–86.
30. Kullman GL (1980).
“Laser Palliation of bronchogenic carcinoma.”
J Fla Med Assoc 67, 566.
31. Kato H, Okunaka, T (1995).
“Photodynamic therapy in early tumors: Combined
use of Photodynamic therapy and surgery” in:
Minimally invasive techniques in thoracic medicine
and surgery, Hetzel MR (Ed.), Chapman & Hall
Medical, London, pp. 149–171
32. Lam S, Becker HD (1996).
“Future diagnostic procedures.”
Chest Surgery Clinics N America 6, 363–380.
33. Lam S, Hung JYC, Kennedy SM et al. (1992).
“Detection of dysplasia and carcinoma in situ by
ratio fluorometry.”
Am. Rev. Respir. Dis 146, 1458–1461
34. Lam S, Hung J, Placic B (1990).
“Detection of lung cancer by ratio fluorometry with
and without Photofrin II.”
SPIE Optical Fibers Med V 1201, 561–568
35. Lam S, Kennedy T, Unger M et al (1998).
“Localization of bronchial intraepithelial neoplastic
lesions by fluorescence bronchoscopy.”
Chest 113, 969-702
36. Leonhard M (1999); “New Incoherent Autofluorescen-
ce/Fluorescence System for Early Detection of Lung
Cancer”; Diagnostic and Therapeutic Endoscopy;
5, 113-118
37. Nakhosteen JA (1999).
“Autofluorescence Bronchoscopy. The Laser Imaging
Fluorescence Endoscope (LIFE®).”
Personal communication.
38. Ono R, Hirano H, Egawa S, Suemasu K (1994).
“Bronchoscopic ultrasonography and brachy-
therapy in roentgenologically occult bronchogenic
carcinoma.”
J Bronchol 1, 281-7.
39. Palcic B, Lam S, Hung J, et al (1991).
“Detection and localization of early lung cancer by
imaging techniques.” Chest 99, 742–743.
40. Philipp CM, Rohde E, Berlien HP (1995).
“Nd:YAG laser procedures in tumor treatment.”
Semin Surg Oncol 11, 290–298.
41. Rall DP, Loo TL, Lane M et al. (1957).
“Appearance and persistence of fluorescent material
in tumor tissue after tetracycline administration.”
J Natl Cancer Inst 19, 79–84.
42. Schantz SP (1993).
“Chemoprevention strategies:
the relevance of premalignant and malignant lesions
of the upper aerodigestive tract”
J Cell Biochem Suppl 17F, 18–26.
43. Saeed, AH, (1980).
“Our Experience with Transbronchial Segmental
Biopsie” in: Bronchology Research, Diagnostic and
Therapeutic Aspects, Ed. J.A.; Nakhosteen and
W. Maasen, 339–341 (Martinus Nijhof)
44. Sugio K, Kishimoto Y, Virmani Ak, Hung JY,
Gazdar AF (1994).
“K-ras mutations are a relatively late event in the
pathogenesis of lung carcinomas.” Cancer Res 54,
5811–5815.
45. Svaasand LO, Doiron DR (1983).
“On the probability for simultaneous action of hyper-
thermal and photodynamic effects during photo-
radiation therapy for malignant tumors.”
Proceedings of an international symposium on
porphyrins in tumor phototherapy. Milan, Italy.
46. Saito Y, Nagamoto N, Ota S et al (1992).
“Results of surgical treatment for roentgenographical-
ly occult bronchogenic squamous cell carcinoma.”
J Thorac Cardiovasc Surg 104, 401–407
47. Von Tappeiner H, Jesionek A (1903).
“Zur Behandlung der Hautcarcinome mit fluorescie-
renden Stoffen.” Münch Med Wochenschr 1,
2042–2044.
48. Waller DA, Gower A, Kashyap Ap, Conacher ID,
Morritt GN (1994).
“Carbon dioxide laser surgery. A review of its use in
the treatment of malignant tracheobronchial tumors
in 142 patients.” Respir Med 88, 737–741.
49. Woolner LB, Fontana RS, Cortese DA et al (1984).
“Roentgenographically occult lung cancer:
Pathologic findings and frequency of multicentricity
during a 10 year period.”
Mayo Clin. Proc. 59, 453–466.
Back –––––––Table of Contents–––––––Next
Back –––––––Table of Contents–––––––Next
